Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02367274 · ClinicalTrials.gov registry record

Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department

A clinical trial of Brain Injuries, sponsored by BrainScope Company.

Completed
Registry status
421
Enrollment target
11
Study locations

NCT02367274: Completed study of Brain Injuries, sponsored by BrainScope Company.

NCT02367274 is a study of Brain Injuries that has completed, run by BrainScope Company. The registered enrollment target is 421 participants, above the 312-participant average among 22 other Brain Injuries trials with a reported enrollment target (35% higher). The trial reports 11 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02367274, a study of Brain Injuries, has completed, sponsored by BrainScope Company.

COMPLETED
Registry status
421 participants
Enrollment target
11
Study locations

Study Summary

A prospective, non-randomized trial for the extension and replication of the development database of brain electrical activity recordings and clinical information collected from patients who present to the ED following closed head injury.

Conditions Studied

Interventions

  • DEVICE BrainScope Ahead 200

Study Locations (11)

Michigan

  • Wayne State University - Detroit Receiving Hospital - Detroit
  • Wayne State University - Sinai Grace Hospital - Detroit

Texas

  • Baylor University Medical Center - Dallas
  • UT-Houston Health Science Center - Houston

Connecticut

  • Hartford Hospital - Hartford

Georgia

  • Emory University- Grady Hospital - Atlanta

Maryland

  • R Cowley Shock Trauma Hospital - Baltimore

Missouri

  • Washington University - Barnes Jewish Hospital - St Louis

New York

  • University of Rochester Medical Center - Rochester

Pennsylvania

  • Allegheny General Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 421 participants
Start Date 2015-01
Est. Completion 2016-04
BrainScope Company

10 total trials

What the finished NCT02367274 record still lists

NCT02367274 is an observational study that tracks outcomes without assigning an intervention. The registered 421 participants enrollment target is mid-sized for trials with a published cap, above the 312-participant average among 22 other Brain Injuries trials with a reported enrollment target (35% higher).

The record links to 1 condition, with Brain Injuries appearing as the primary indexed condition, and to 1 intervention - of which BrainScope Ahead 200 is the first listed.

NCT02367274 lists 11 locations in 9 states (Michigan, Texas, Connecticut).

Frequently Asked Questions

What is clinical trial NCT02367274 about?

NCT02367274 is a clinical study titled "Point-Of-Care TBI Detection System For Head Injured Patients In The Emergency Department". A prospective, non-randomized trial for the extension and replication of the development database of brain electrical activity recordings and clinical information collected from patients who present to the ED following closed head injury.

What is the current status of trial NCT02367274?

This trial is currently completed. The enrollment target is 421 participants. The study started on 2015-01. Estimated completion is 2016-04.

What conditions does trial NCT02367274 study?

This clinical trial studies the following conditions: Brain Injuries.

What interventions are being tested in trial NCT02367274?

The interventions under investigation include: BrainScope Ahead 200 (DEVICE).

Who is sponsoring clinical trial NCT02367274?

This trial is sponsored by BrainScope Company, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02367274 being conducted?

This trial has 11 study locations across Connecticut, Georgia, Maryland, Michigan, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02367274's enrollment target sits among peer trials

421 4th of 22 higher than 19 of 22 other Brain Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Brain Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05976763 · 421 participants · Phase 3

    Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT07114601 · 421 participants · Phase 1

    A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • NCT04763356 · 422 participants · NA

    Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy

  • NCT06837246 · 422 participants · NA

    A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02367274, the US trial registry maintained by the National Library of Medicine. NCT02367274 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.